human monocyte derived macrophages supporting...
TRANSCRIPT
-
Bridgette M. Cumming1, Kelvin Addicott1, John H. Adamson1, Adrie J.C. Steyn1,21Africa Health Research Institute, Durban, South Africa;
2Department of Microbiology, UAB Center for AIDS Research, University of Alabama at Birmingham, USA
Mycobacterium tuberculosis infection decelerates bioenergetic metabolism and alters mitochondrial substrate preferences in the macrophage host
SUPPORTING COMPANY LOGOS
• About 1/3 of the world’s population is latently infected with Mycobacterium tuberculosis (Mtb)1.
• Infection with Mtb does not confer immunity against future infections demonstrating Mtb hasdefinitive strategies to manipulate the immune response and prevent complete eradication.
• At the onset of tuberculosis infection, macrophages phagocytose Mtb as the first line of defence.Several studies have indicated that Mtb infection of murine bone marrow derived macrophagesresults in a shift to aerobic glycolysis that induces the production of pro-inflammatory cytokines2,3.
• To further our understanding of Mtb modulation of the macrophage to consider host-directedadjunctive therapy as a novel intervention against TB, we investigated how Mtb tempers thebioenergetic metabolism of human monocyte derived macrophages using extracellular flux andmetabolite analyses.
Introduction
• Human monocyte derived macrophages (hMDMs) were infected with Mtb H37Rv, M. bovis BCG(BCG) or heat killed Mtb (Dead Mtb) at multiplicities of infection (MOI) of 1, 2.5 or 5 (as indicated)for 24 hrs.
• The infected macrophages were analysed for their:• Overall bioenergetic status using extracellular flux technology (Agilent Seahorse XF96).• Metabolite levels and isotopomers after incubation with [U-13C]glucose using LC-MS/MS and
13C-tracing.
Methods
Mtb infection modulates the bioenergetic phenotype of
macrophages distinct to that of BCG and heat killed Mtb
infections
0 2 0 4 0 6 0 8 0 1 0 0
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
M O I 1
T im e (m in )
gly
co
PE
R (
pm
ol/
min
) h M D M
M tb M O I 1
B C G M O I 1
D e a d M tb M O I 1
R ot& A n tiA 2 -D G
0 2 0 4 0 6 0 8 0 1 0 0
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
M O I 2 .5
T im e (m in )
gly
co
PE
R (
pm
ol/
min
) h M D M
M tb M O I 2 .5
B C G M O I 2 .5
D e a d M tb M O I 2 .5
R ot& A n tiA 2 -D G
0 2 0 4 0 6 0 8 0 1 0 0
0
1 0 0
2 0 0
3 0 0
M O I 5
T im e (m in )
gly
PE
R (
pm
ol/
min
)
h M D M
M tb M O I 5
B C G M O I 5
D e a d M tb M O I 5
R ot& A n tiA 2 -D G
B a s a l C o m p e n s a to ry
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0M O I 1
gly
co
PE
R (
pm
ol/
min
) h M D M
M tb M O I 1
B C G M O I 1
D e a d M tb M O I 1
+
B a s a l C o m p e n s a to ry
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
M O I 2 .5
gly
co
PE
R (
pm
ol/
min
) h M D M
M tb M O I 2 .5
B C G M O I 2 .5
D e a d M tb M O I 2 .5
*
B a s a l C o m p e n s a to ry
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
M O I 5
gly
co
PE
R (
pm
ol/
min
) h M D M
M tb M O I 5
B C G M O I 5
D e a d M tb M O I 5
#
#
A B C
D E F
Figure 1. Increasing MOI of Mtb depresses mitochondrial respiration in hMDM in contrast to BCG infection,
which increases the spare respiratory capacity of the hMDMs. (A-C) Cell Mito Stress Test (CMST) of hMDM
infected with increasing MOI of Mtb, BCG and heat-killed Mtb for 24 hrs. (D-F) Respiratory parameters of the
macrophages calculated from the CMST. (G-I) Phenograms demonstrating a shift in Mtb infected hMDMs towards an
energy phenotype reminiscent of quiescence at an MOI of 5.
Figure 2. Unlike BCG infection, Mtb does not increase the rate of glycolysis in hMDMs. (A-C) Glycolytic Rate
Assay of hMDM infected with increasing MOI of Mtb, BCG and heat-killed Mtb for 24 hrs. (D-F) Basal Glycolysis and
compensatory glycolysis of the macrophages expressed as proton efflux rate (PER, pmol/min) as determined from the
Glycolytic Rate Assay on the XF96. The glycolytic proton efflux rate gives a direct measure of the acidification rate due
to glycolysis without the acidification contribution from mitochondrial respiration.
Figure 3. Mtb infection decelerates bioenergetic metabolism in hMDMs.13C-tracing of metabolites
extracted from hMDM infected with Mtb, BCG or heat-killed Mtb at an MOI of 4 for 24 hours. Less 13C
incorporation is observed in the metabolites of glycolysis, TCA cycle and the pentose phosphate pathway
of the Mtb infected hMDMs in comparison to the uninfected hMDMs and those that are infected with BCG
and heat-killed Mtb. Although the levels of the glycolytic intermediates are decreased in all of the infected
hMDMs, the levels of the TCA cycle intermediates from Mtb infected hMDMs are higher possibly due to
lack of cycling through the TCA cycle.
Glc
UI
Glc
Mtb
Glc
BC
G
Glc
D
ead
Mtb
Gln
UI
Gln
Mtb
Gln
BC
G
Gln
D
ead
Mtb
FA
UI
FA
Mtb
FA
BC
G
FA
D
ead
Mtb
0
2 5
5 0
7 5
1 0 0
Fu
el
ox
ida
tio
n
(% o
f G
lc+
Gln
+F
A o
xid
ati
on
)
% D e p e n d e n c y
% F le x ib ility
+ +
+
+*
+
+
*
#
*
#
0 2 0 4 0 6 0
2 5
5 0
7 5
1 0 0
1 2 5
1 5 0
O x a m a te
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ole
s/m
in/
g p
ro
tein
)
U I
U I+ 2 0 m M
M tb 1
M tb 1 + 2 0 m M
M tb 5
M tb 5 + 2 0 m M
0 1 0 2 0 3 0 4 0 5 0
2 5
5 0
7 5
1 0 0
1 2 5
2 -D e o x y g lu c o s e
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ole
s/m
in/
g p
ro
tein
)
U I
U I+ 2 0 m M
M tb 1
M tb 1 + 2 0 m M
M tb 5
M tb 5 + 2 0 m M
M tb 5 + 3 0 m M
1 5 2 0 2 5 3 0
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
D ic h lo r o a c e tic a c id
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ole
s/m
in/
g p
ro
tein
)
U I
U I+ 1 0 m M
U I+ 2 0 m M
U I+ 3 0 m M
M tb
M tb + 1 0 m M
M tb + 2 0 m M
M tb + 3 0 m M
D e a d M tb
Figure. 4. Inhibition of glycolysis (2-deoxyglucose) or lactate production (oxamate and
dichloroacetic acid) do not redirect the bioenergetic metabolism of Mtb infected macrophages
towards OXPHOS. Phenograms of uninfected and Mtb (1 or 5: MOI) hMDM cells treated with (A)
oxamate (B) 2-deoxyglucose (C) and RAW264.7 cells (Mtb, MOI 5) treated with dichloroacetic acid.
Circles: uninfected macrophages, Squares: Mtb infected macrophages.
Inhibition of glycolysis in Mtb infected macrophages does not redirect energy metabolism to OXPHOS
Mtb infection alters mitochondrial substrate preference of the macrophage
Mtb infection decelerates bioenergetic metabolism of the macrophage
Figure 5. Mtb infection decreases the mitochondrial
dependency on glucose and increases the dependency on
glutamine and fatty acid oxidation. hMDM were infected with
Mtb, BCG and heat-killed Mtb (MOI 4) for 24 hrs prior to
conducting the Mitochondrial Fuel Flex Test on the XF96. Glc,
glucose; Gln, glutamine; FA, fatty acids
• Basal respiration, ATP-linked OCR and maximalrespiration are reduced in Mtb infected hMDMs withincreasing MOI in contrast to infection with BCG andheat-killed Mtb that do not affect respiration at lowMOIs.
• Furthermore, BCG infection increases the maximalrespiration and the spare respiratory capacity ofhMDMs above that of uninfected hMDMs.
• Unlike BCG or heat killed Mtb infection, Mtb infectiondoes not increase the rate of basal glycolysis orcompensatory glycolysis in hMDMs.
• Mtb infection decelerates flux through glycolysis andthe TCA cycle of the hMDMs, confirming the observedshift to a quiescent energy phenotype.
• ADP/ATP and AMP/ATP ratios increase in Mtb infectedhMDMs supporting the overserved reduced rates ofOXPHOS and glycolysis.
• Inhibition of glycolysis or lactate production did notredirect the bioenergetic metabolism of the macrophageto OXPHOS suggesting that Mtb has an irreversibledepressive effect on mitochondrial respiration.
• Mtb infection of hMDMs changes the substratepreference of mitochondria from glucose to glutamineand fatty acids, whereas heat-killed Mtb increases thedependency of the macrophages on glucose with noflexibility.
• Mtb infection of hMDMs slows down energy metabolismof the host cell, including both OXPHOS and glycolysis.This is probably part of Mtb’s strategy to “diminish” theinnate immune functions of the macrophage and delayapoptosis of the macrophage to sustain bacilli growth.
• Future work includes investigating the “apoptotic status”of Mtb infected hMDMs displaying the quiescent energyphenotype.
Conclusions
This work was supported by the National Institutes ofHealth grants R01 AI 111 940 and R21 127182 and theUAB Center for AIDS Research.
Acknowledgements
References1. Global TB Report, 2017, WHO.
2. Gleeson et al. (2016) J. Immun. Vol. 196, pp. 2444;
3. Stanley et al. (2016) Vol. 197, pp. 1287
0 2 5 5 0 7 5 1 0 0
0
2 0
4 0
6 0
8 0
1 0 0
T im e (m in u te s )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tb M O I 1
B C G M O I 1
D e a d M tb M O I 1
O lig o F C C P A n tiA & R o t
M O I 1
0 2 5 5 0 7 5 1 0 0
0
2 0
4 0
6 0
8 0
1 0 0
T im e (m in u te s )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tb M O I 2 .5
B C G M O I 2 .5
D e a d M tb M O I 2 .5
O lig o F C C P A n tiA & R o t
M O I 2 .5
0 2 5 5 0 7 5 1 0 0
0
2 0
4 0
6 0
8 0
1 0 0
T im e (m in u te s )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tb M O I 5
B C G M O I 5
D e a d M tb M O I 5
O lig o F C C P A n tiA & R o t
M O I 5
Basal
AT
P P
rod
uct i
on
Pro
ton
Leak
Max R
esp
SR
C
No
n M
ito
Resp
0
2 0
4 0
6 0
8 0
OC
R (
pm
ol/
min
/g
pro
tein
) U I
M tb
B C G
D e a d M tb
+
+ +
+
*
+
M O I 1
Basal
AT
P T
urn
over
Pro
ton
Leak
Max R
esp
SR
C
No
n M
ito
Resp
0
2 0
4 0
6 0
8 0
OC
R (
pm
ol/
min
/g
pro
tein
)
*
+
#
+
#
# *
+
+
+
M O I 2 .5
Basal
AT
P T
urn
over
Pro
ton
Leak
Max R
esp
SR
C
No
n M
ito
Resp
0
2 0
4 0
6 0
8 0
OC
R (
pm
ol/
min
/g
pro
tein
)
#
#
#
#
#
*
#
#
#
#
M O I 5
0 5 1 0 1 5
0
1 0
2 0
3 0
4 0
5 0
M O I 1
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tbB C G
M tb
Q u ie s c e n t G ly c o ly t ic
A e ro b ic E n e rg e t ic
0 5 1 0 1 5
0
1 0
2 0
3 0
4 0
5 0
M O I 2 .5
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tb
M tb
B C G
0 5 1 0 1 5
0
1 0
2 0
3 0
4 0
5 0
M O I 5
E C A R (m p H /m in / g p ro te in )
OC
R (
pm
ol/
min
/ g
pro
tein
)
U I
M tb
B C G
M tb
A B C
D E F
G H I
A B C